BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23328228)

  • 1. Intraductal delivery of adenoviruses targets pancreatic tumors in transgenic Ela-myc mice and orthotopic xenografts.
    José A; Sobrevals L; Miguel Camacho-Sánchez J; Huch M; Andreu N; Ayuso E; Navarro P; Alemany R; Fillat C
    Oncotarget; 2013 Jan; 4(1):94-105. PubMed ID: 23328228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse models.
    Huch M; Gros A; José A; González JR; Alemany R; Fillat C
    Neoplasia; 2009 Jun; 11(6):518-28, 4 p following 528. PubMed ID: 19484141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens.
    Lafitte M; Rousseau B; Moranvillier I; Taillepierre M; Peuchant E; Guyonnet-Dupérat V; Bedel A; Dubus P; de Verneuil H; Moreau-Gaudry F; Dabernat S
    Mol Cancer; 2012 Oct; 11():81. PubMed ID: 23088623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic adenoviruses armed with thymidine kinase can be traced by PET imaging and show potent antitumoural effects by ganciclovir dosing.
    Abate-Daga D; Andreu N; Camacho-Sánchez J; Alemany R; Herance R; Millán O; Fillat C
    PLoS One; 2011; 6(10):e26142. PubMed ID: 22028820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic fiber modification to achieve matrix-metalloprotease-activated infectivity of oncolytic adenovirus.
    José A; Rovira-Rigau M; Luna J; Giménez-Alejandre M; Vaquero E; García de la Torre B; Andreu D; Alemany R; Fillat C
    J Control Release; 2014 Oct; 192():148-56. PubMed ID: 25037019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors.
    Yamamoto Y; Nagasato M; Rin Y; Henmi M; Ino Y; Yachida S; Ohki R; Hiraoka N; Tagawa M; Aoki K
    Cancer Med; 2017 Oct; 6(10):2385-2397. PubMed ID: 28941156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy.
    Hakkarainen T; Hemminki A; Curiel DT; Wahlfors J
    Int J Mol Med; 2006 Oct; 18(4):751-9. PubMed ID: 16964432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal insulin promoter-thymidine kinase gene therapy followed by ganciclovir effectively ablates human pancreatic cancer in mice.
    Wu JX; Liu SH; Nemunaitis JJ; Brunicardi FC
    Cancer Lett; 2015 Apr; 359(2):206-10. PubMed ID: 25596375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir.
    Zhou H; He Z; Wang C; Xie T; Liu L; Liu C; Song F; Ma Y
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27275821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.
    Chu QD; Sun G; Pope M; Luraguiz N; Curiel DT; Kim R; Li BD; Mathis JM
    Surgery; 2012 Sep; 152(3):441-8. PubMed ID: 22853858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer.
    Ohashi M; Kanai F; Tanaka T; Lan KH; Shiratori Y; Komatsu Y; Kawabe T; Yoshida H; Hamada H; Omata M
    Jpn J Cancer Res; 1998 Apr; 89(4):457-62. PubMed ID: 9617353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation.
    Maliandi MV; Mato-Berciano A; Sobrevals L; Roué G; José A; Fillat C
    Mol Cancer; 2015 Jul; 14():146. PubMed ID: 26227809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice.
    Liu SH; Smyth-Templeton N; Davis AR; Davis EA; Ballian N; Li M; Liu H; Fisher W; Brunicardi FC
    Surgery; 2011 Apr; 149(4):484-95. PubMed ID: 21295812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer.
    Freytag SO; Barton KN; Brown SL; Narra V; Zhang Y; Tyson D; Nall C; Lu M; Ajlouni M; Movsas B; Kim JH
    Mol Ther; 2007 Sep; 15(9):1600-6. PubMed ID: 17551507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. uPAR-controlled oncolytic adenoviruses eliminate cancer stem cells in human pancreatic tumors.
    Sobrevals L; Mato-Berciano A; Urtasun N; Mazo A; Fillat C
    Stem Cell Res; 2014 Jan; 12(1):1-10. PubMed ID: 24141108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific promoter-driven adenoviral therapy for insulinoma.
    Tseng AW; Chen C; Breslin MB; Lan MS
    Cell Oncol (Dordr); 2016 Jun; 39(3):279-86. PubMed ID: 26902080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
    Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C
    Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene.
    Rosenfeld ME; Vickers SM; Raben D; Wang M; Sampson L; Feng M; Jaffee E; Curiel DT
    Ann Surg; 1997 May; 225(5):609-18; discussion 618-20. PubMed ID: 9193188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.